Lack of Efficacy of Low Doses of Quetiapine Addition in Refractory Obsessive-Compulsive Disorder
Authors:
- Levent SevincokLSLevent Sevincok
- Ayse TopuzATAyse Topuz
- 1 October 2003
- journal article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 23 (5) , 448-450
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Quetiapine augmentation in patients with treatment resistant obsessive???compulsive disorder: a single-blind, placebo-controlled studyInternational Clinical Psychopharmacology, 2002
- Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorderInternational Clinical Psychopharmacology, 2002
- A Double-blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor–Refractory Obsessive-compulsive DisorderArchives of General Psychiatry, 2000
- Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder.The Journal of Clinical Psychiatry, 2000
- Olanzapine Addition in Obsessive-Compulsive Disorder Refractory to Selective Serotonin Reuptake InhibitorsThe Journal of Clinical Psychiatry, 1999
- Quetiapine in Patients With SchizophreniaArchives of General Psychiatry, 1997
- ‘Seroquel’ (quetiapine), a promising new antipsychotic agent: Overview of safety and tolerabilitySchizophrenia Research, 1997
- The serotonin hypothesis of obsessive compulsive disorder1International Clinical Psychopharmacology, 1993
- Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorderAmerican Journal of Psychiatry, 1990
- The Yale-Brown Obsessive Compulsive ScaleArchives of General Psychiatry, 1989